253 related articles for article (PubMed ID: 20674950)
1. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.
Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL
Surgery; 2011 Feb; 149(2):209-20. PubMed ID: 20674950
[TBL] [Abstract][Full Text] [Related]
2. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
[TBL] [Abstract][Full Text] [Related]
3. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the surgical effort in patients with advanced neuroendocrine neoplasm hepatic metastases: a critical analysis of 40 patients treated by hepatic resection and cryoablation.
Saxena A; Chua TC; Chu F; Al-Zahrani A; Morris DL
Am J Clin Oncol; 2012 Oct; 35(5):439-45. PubMed ID: 21654315
[TBL] [Abstract][Full Text] [Related]
5. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for liver metastases of neuroendocrine tumors.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Nakayama T; Tabata Y; Shichinohe T
Hepatogastroenterology; 2012 May; 59(115):921-3. PubMed ID: 22024223
[TBL] [Abstract][Full Text] [Related]
7. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
8. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
[TBL] [Abstract][Full Text] [Related]
10. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
11. Liver metastases from colorectal cancer: present surgical approach.
Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
[TBL] [Abstract][Full Text] [Related]
12. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis.
Mayo SC; de Jong MC; Pulitano C; Clary BM; Reddy SK; Gamblin TC; Celinksi SA; Kooby DA; Staley CA; Stokes JB; Chu CK; Ferrero A; Schulick RD; Choti MA; Mentha G; Strub J; Bauer TW; Adams RB; Aldrighetti L; Capussotti L; Pawlik TM
Ann Surg Oncol; 2010 Dec; 17(12):3129-36. PubMed ID: 20585879
[TBL] [Abstract][Full Text] [Related]
14. [Is liver transplantation as surgical therapy concept in metastases of neuroendocrine tumors justified?].
Lang H; Oldhafer KJ; Schlitt HJ; Scheumann GF; Ringe B; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():416-8. PubMed ID: 9101890
[TBL] [Abstract][Full Text] [Related]
15. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
17. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of liver metastases from gastrointestinal endocrine tumors.
Boleslawski E; Dharancy S; Truant S; Pruvot FR
Gastroenterol Clin Biol; 2010; 34(4-5):274-82. PubMed ID: 20347242
[TBL] [Abstract][Full Text] [Related]
19. Hepatic ablation for neuroendocrine tumor metastases.
Maithel SK; Fong Y
J Surg Oncol; 2009 Dec; 100(8):635-8. PubMed ID: 20017158
[TBL] [Abstract][Full Text] [Related]
20. [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].
Scheele J; Altendorf-Hofmann A; Stangl R; Schmidt K
Swiss Surg; 1996; Suppl 4():4-17. PubMed ID: 8963836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
